The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

Less than five years on from when Novo Nordisk's semaglutide drug received FDA approval for weight loss (Wegovy), the Danish pharmaceutical company has announced it will seek regulatory approval ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they will be prohibiting like-for-like compounded versions.

Most compounded versions of popular drugs used for weight ... to go through the FDA's rigorous approval process. Zepbound is approved by the FDA as a weight loss management treatment for people ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...